BLOOD RESEARCH Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-0011   pISSN 2287-979X

 

Cited by CrossRef (12)

  1. S. A. Shutov, A. V. Kovalenko, O. A. Soboleva, N. V. Prasolov, K. I. Danishyan. Surgical treatment of the complication of urolithiasis in patients with inhibitor form of hemophilia. Khir. Z. im. N.I. Pirogova 2017:104
    https://doi.org/10.17116/hirurgia20173104-107
  2. R. Hartmann, T. Feenstra, L. Valentino, M. Dockal, F. Scheiflinger. In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents. J Thromb Haemost 2018;16:1580
    https://doi.org/10.1111/jth.14203
  3. Shamsoreza Tabriznia-Tabrizi, Marzie Gholampour, Hassan Mansouritorghabeh. A close insight to factor VIII inhibitor in the congenital hemophilia A. Expert Review of Hematology 2016;9:903
    https://doi.org/10.1080/17474086.2016.1208554
  4. Daniel P. Hart, Charles R.M. Hay, Ri Liesner, Guillermo Tobaruela, Bethan Du-Mont, Mike Makris. Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors. 2019;30:309
    https://doi.org/10.1097/MBC.0000000000000840
  5. Zühre Kaya, Özlem Orhan, Sacit Turanlı, İdil Yenicesu, Ülker Koçak, Türkiz Gürsel. Successful total hip replacement with sequential administration of bypassing agents in an adolescent boy with hemophilia A and high inhibitor titers. 2017;28:419
    https://doi.org/10.1097/MBC.0000000000000617
  6. Lucia S. D'Angiolella, Paolo A. Cortesi, Angiola Rocino, Antonio Coppola, Hamisa J. Hassan, Adele Giampaolo, Luigi P. Solimeno, Alessandra Lafranconi, Mariangela Micale, Sveva Mangano, Giacomo Crotti, Federica Pagliarin, Giancarlo Cesana, Lorenzo G. Mantovani. The socioeconomic burden of patients affected by hemophilia with inhibitors. Eur J Haematol 2018;101:435
    https://doi.org/10.1111/ejh.13108
  7. Rie Shirayama, Hideyuki Takedani, Yushi Chikasawa, Akira Ishiguro, Masataka Ishimura, Kiyotaka Isobe, Mitsuhiro Uchiba, Yoshiyasu Ogata, Harumi Kakuda, Koichi Kusuhara, Akira Shirahata. Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitors. 2019;30:385
    https://doi.org/10.1097/MBC.0000000000000851
  8. Sibylle A. Kozek-Langenecker, Aamer B. Ahmed, Arash Afshari, Pierre Albaladejo, Cesar Aldecoa, Guidrius Barauskas, Edoardo De Robertis, David Faraoni, Daniela C. Filipescu, Dietmar Fries, Thorsten Haas, Matthias Jacob, Marcus D. Lancé, Juan V.L. Pitarch, Susan Mallett, Jens Meier, Zsolt L. Molnar, Niels Rahe-Meyer, Charles M. Samama, Jakob Stensballe, Philippe J.F. Van der Linden, Anne J. Wikkelsø, Patrick Wouters, Piet Wyffels, Kai Zacharowski. Management of severe perioperative bleeding. 2017;34:332
    https://doi.org/10.1097/EJA.0000000000000630
  9. Gurhan Erturan, Borna Guevel, Abtin Alvand, Nicholas J. Goddard. Over two decades of orthopaedic surgery in patients with inhibitors-Quantifying the complication of bleeding. Haemophilia 2019;25:21
    https://doi.org/10.1111/hae.13647
  10. Rudolf Hartmann, Tjerk Feenstra, Sabine Knappe, Gerald Schrenk, Friedrich Scheiflinger, Michael Dockal. A bispecific antibody demonstrates limited measurability in routine coagulation assays. 2020;31:353
    https://doi.org/10.1097/MBC.0000000000000921
  11. Jenny Kwak, Michael Mazzeffi, Lisa N. Boggio, Mindy L. Simpson, Kenichi A. Tanaka. Hemophilia: A Review of Perioperative Management for Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia 2020
    https://doi.org/10.1053/j.jvca.2020.09.118
  12. Victor Jiménez‐Yuste, E. Carlos Rodríguez‐Merchán, Tadashi Matsushita, Pål Andrè Holme. Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery. Haemophilia 2021
    https://doi.org/10.1111/hae.14322